| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/27/2011 | WO2011011543A1 Oligomer-opioid agonist conjugates |
| 01/27/2011 | WO2011011420A2 3, 4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor |
| 01/27/2011 | WO2011011376A2 Methods for the preparation and use of aqueous solutions of magnesium valproate hydrate and l-carnitine |
| 01/27/2011 | WO2011011330A2 Inhibitors of d-amino acid oxidase |
| 01/27/2011 | WO2011011123A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 01/27/2011 | WO2011011092A1 Methods and compositions to reduce oxidative stress |
| 01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
| 01/27/2011 | WO2011010682A1 Sterol derivative |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2011010364A1 Compound having neurite-outgrowing activity |
| 01/27/2011 | WO2011010332A1 Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2011010015A1 Piperidine compounds, method for preparing same, and pharmaceutical compositions containing same |
| 01/27/2011 | WO2011010013A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway |
| 01/27/2011 | WO2011009951A1 1h-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis |
| 01/27/2011 | WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | WO2011009898A1 Fused aminodihydro-oxazine derivatives |
| 01/27/2011 | WO2011009897A1 Fused aminodihydropyrimidone derivatives |
| 01/27/2011 | WO2011009862A1 Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission |
| 01/27/2011 | WO2011009861A1 Black pepper extract or its constituents for improving mental performance |
| 01/27/2011 | WO2011009831A1 Process for the purification of olanzapine |
| 01/27/2011 | WO2011009193A1 Combinations of curcummoids and mtor inhibitors for the treatment of tauopathies |
| 01/27/2011 | WO2010142956A3 Aroylthiourea and arylthiocarbonylurea derivatives |
| 01/27/2011 | WO2010134814A3 Means and methods for counteracting polyq expansion disorders |
| 01/27/2011 | WO2010130424A9 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| 01/27/2011 | WO2010113179A3 Process for purifying eslicarbazepine acetate |
| 01/27/2011 | US20110021972 Composition and Device Structure For Iontophoresis |
| 01/27/2011 | US20110021792 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021633 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States |
| 01/27/2011 | US20110021628 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG |
| 01/27/2011 | US20110021625 Neuronal cell death inhibitor |
| 01/27/2011 | US20110021613 Plants extracts for use in brain modulation |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021597 3-phenoxymethylpyrrolidine compounds |
| 01/27/2011 | US20110021596 Topical therapy for migraine |
| 01/27/2011 | US20110021594 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
| 01/27/2011 | US20110021590 Aminopyrrolidinone derivatives and uses thereof |
| 01/27/2011 | US20110021589 Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
| 01/27/2011 | US20110021586 Phenyl-sulfamates as aromatase inhibitors |
| 01/27/2011 | US20110021583 Enhanced transmucosal composition and dosage form |
| 01/27/2011 | US20110021578 Compounds which Potentiate the AMPA Receptor and Uses Thereof in Medicine |
| 01/27/2011 | US20110021577 Aryloxy amine compounds and their use as sodium channel modulators |
| 01/27/2011 | US20110021571 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 01/27/2011 | US20110021569 Piperidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/27/2011 | US20110021565 Piperidine derivatives as nk3 antagonists |
| 01/27/2011 | US20110021562 Treatment of friedreich's ataxia using histone deacetylase inhibitors |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021556 Pyrrolidinyl derivatives and uses thereof |
| 01/27/2011 | US20110021552 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021538 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/27/2011 | US20110021535 Trazodone Composition for Once a Day Administration |
| 01/27/2011 | US20110021533 Cysteine prodrugs to treat schizophrenia and drug addiction |
| 01/27/2011 | US20110021531 Oxazole derivatives useful as inhibitors of faah |
| 01/27/2011 | US20110021529 P53 activating compounds |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021520 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021516 Monocyclic cgrp receptor antagonists |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021510 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 01/27/2011 | US20110021508 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
| 01/27/2011 | US20110021507 Inhibiting antipsychotic-induced weight gain |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021503 Use and composition for treating dementia |
| 01/27/2011 | US20110021502 Use of cholinesterase inhibitors for treating vascular depression |
| 01/27/2011 | US20110021501 Substituted piperazino-dihydrothienopyrimidines |
| 01/27/2011 | US20110021500 Novel compounds |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021490 Chromene compounds, a process for their preparationand pharmaceutical compositions containing them |
| 01/27/2011 | US20110021488 New Compounds |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021482 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents |
| 01/27/2011 | US20110021481 Novel Compounds and Methods for Their Production |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | US20110021471 REDUCING Abeta42 LEVELS AND Abeta AGGREGATION |
| 01/27/2011 | US20110021469 baclofen solution for low-volume therapeutic delivery |
| 01/27/2011 | US20110021466 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021458 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrine, which can be used in the treatment of alcohol and cocaine dependence |
| 01/27/2011 | US20110021437 Method for reducing pain with ziconotide and baclofen |
| 01/27/2011 | US20110021436 Method for reducing pain with ziconotide and morphine |
| 01/27/2011 | US20110021435 Composition for preventing or treating brain diseases |
| 01/27/2011 | US20110021434 Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof |
| 01/27/2011 | US20110021426 Methods for treatment of pain |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110020480 Use of benzoxazinoids-containing cereal grain products for health-improving purposes |
| 01/27/2011 | US20110020478 Method for treating neural injuries |
| 01/27/2011 | US20110020466 Fertilized egg isolate and use thereof |
| 01/27/2011 | US20110020463 Therapeutic agent for fibromyalgia syndrome and therapeutic agent for pain caused by muscle spasm |